Friday

10th Apr 2020

Opinion

GMO industry is playing Russian roulette with our food

  • 'There is no scientific consensus to support the assertion that GMOs are safe' (Photo: swerz)

Multinational biotech companies and several scientists are playing Russian roulette with our food and farming systems. They claim that genetically modified organisms (GMOs) are a safe bet, just because the bullet is still in the chamber.

Some commentators – including in this publication – have fallen for the myth of a scientific consensus on the safety of GMOs. They accuse anti-GMO campaigners of sowing doubt. This accusation is a gross misrepresentation of the scientific debate in Europe and elsewhere.

Read and decide

Join EUobserver today

Support quality EU news

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

Regulators are sometimes also taken in. The European Commission maintains that there is no evidence of harm and that any disagreement with EU countries is not about the science. In reality, over a period of 15 years, many countries have expressed scientific concerns about the safety of GMOs and EU risk assessment procedures.

The myth of consensus

Already in 2008, EU countries unanimously raised concerns about the EU risk assessment process. In 2009, EU countries formally confronted the Commission with unresolved scientific questions about GM crops. Several governments also raised scientific concerns to justify bans on the cultivation of GM crops on their territories.

There is no scientific consensus to support the assertion that GMOs are safe.

Genetic engineering radically alters the characteristics of organisms in ways that do not occur in nature. This is why the UN established a convention on biosafety, the Cartagena Protocol, to protect biological diversity from the effects of GMOs.

Studies purporting the safety of GM crops often omit critical scientific concerns. One such review did not detect significant hazards, but omitted the potential impact of insect resistant crops on non-target butterfly species. Furthermore, nearly 400 incidents of GM contamination have been reported to date. These include experimental GM crops which have entered the food chain even though no food safety assessment has been performed.

The regulatory approach lacks rigour. Studies have identified chemical and biological differences between GMOs and conventional crops, but these have not been investigated further. Of most concern, long-term health studies of GM crops are simply not carried out.

In the EU, conclusions on long-term risks to health are based on short 90-day feeding trials.

To date, the vast majority of commercial GM crops display only two traits: herbicide-tolerance and insecticide production. There is much hype surrounding new GM traits, such as altered nutrient composition. These GM traits have not yet materialised into applications for commercialisation, but if they did they would require closer scrutiny and greater rigour by regulators.

This is because, unlike current GM crops, the chemical profile in these GM plants would be deliberately altered. Plant chemistry is complex, and the alteration of one chemical aspect, can lead to other unintended chemical changes.

Copyright on science

One of the main problems with claims about the health and environmental safety of GM crops is that independent scientists are often denied access to research material and the freedom to assess it. Even more worryingly, independent scientists have expressed fears about persecution by pro-GMO industry groups when they publish findings that show negative environmental impacts.

In a recent report, Late lessons from early warnings, the European Environment Agency (EEA) addresses some of the obstacles to independent evaluation of GMOs. It said: “Researchers who have published scientific evidence unfavourable to the interests of GM crop developers have experienced personal and professional attacks on their work, and in some cases leading to threats or loss of research funding and dismissal.”

Absence of evidence is not evidence of absence of harm

GMO supporters often conflate “lack of evidence of harm” with “evidence of no harm”. The evidence we do have is sufficient to warrant concern. Independent studies show adverse effects on living organisms, including toxicity to pollinating insects, contribution to the development of super-weeds, and contamination of other plant species.

A global report on agriculture, conducted by over 400 scientists under the auspices of the FAO, UNDP, UNEP, UNESCO, WHO and the World Bank, supported by 58 governments, concludes that: “Assessment of modern biotechnology is lagging behind development; information can be anecdotal and contradictory, and uncertainty on benefits and harms is unavoidable. There is a wide range of perspectives on the environmental, human health and economic risks and benefits of modern biotechnology; many of these risks are as yet unknown.”

It also stresses that: “There are a limited number of properly designed and independently peer-reviewed studies on human health. […] Among the studies that have been published, some have provided evidence for potential undesirable effects.”

The argument is only strengthened by the fact that GMOs are not necessary in the first place. Other plant breeding technologies, such as marker-assisted selection, are already delivering non-GM crops with traits that farmers desire. Combined with ecological farming, these new techniques can transform the way we produce our food and banish risks associated with GMOs and industrial farming.

As long as scientific evidence is not conclusive and there are reasons to fear negative and irreversible effects from the use of GMOs, the EU must apply the precautionary principle enshrined in law. It is time to quit this game of Russian roulette before it is too late.

Marco Contiero Greenpeace EU agriculture policy director

Disclaimer

The views expressed in this opinion piece are the author's, not those of EUobserver.

Why Europe must act now, and on a big scale

It is still very likely that Europe will face a new deadly spread of the virus next autumn or winter. Until a reliable vaccine and cure are in place, we all have to live in this new reality.

Coronavirus sees approval-rating soar for EU leaders

The rise in support for mainstream parties has been paired with stagnation or decline for far-right populist parties and figures - the AfD has dropped to 10 percent in Germany and Marine Le Pen and Matteo Salvini are treading water.

The future of 'Made in China' after coronavirus?

In repointing Europe's approach to industrial policy, some policymakers have prized China as an example to follow. Luckily, the European Commission is moving towards a European approach.

News in Brief

  1. Migrants trapped on boat in Tripoli due to shelling
  2. EU anti-crisis budget 'could be up to €1.5 trillion'
  3. Western Balkan states appeal for EU help with masks
  4. Spain's lockdown could be extended until 10 May
  5. IMF: Pandemic crisis will be worse than great depression
  6. German economy minister expects progress on EU deal
  7. Italian PM: EU is at risk if no deal on recovery plan
  8. Belgian region to block EU Green Deal

Coronavirus: A test of the West

We are experiencing the first global pandemic unfolding in the 24/7 news cycle and taking its toll, in real time, on our daily lives, our financial security and the global economy.

Stakeholders' Highlights

  1. UNESDAMaking Europe’s Economy Circular – the time is now
  2. Nordic Council of MinistersScottish parliament seeks closer collaboration with the Nordic Council
  3. UNESDAFrom Linear to Circular – check out UNESDA's new blog
  4. Nordic Council of Ministers40 years of experience have proven its point: Sustainable financing actually works
  5. Nordic Council of MinistersNordic and Baltic ministers paving the way for 5G in the region
  6. Nordic Council of MinistersEarmarked paternity leave – an effective way to change norms

Latest News

  1. How the EU's virus-alert agency failed
  2. Flemish nationalists torpedo Belgium Green Deal pledge
  3. Eurozone agreed €500bn cushion against virus blow
  4. Why Europe must act now, and on a big scale
  5. EU court blocks Poland's bid to 'frighten' judges
  6. Coronavirus sees approval-rating soar for EU leaders
  7. EU science chief who 'quit' had been told to resign
  8. EU delays 'exit strategies' plan, as WHO urges caution

Join EUobserver

Support quality EU news

Join us